Howard Lorber, president and CEO of parent company Vector Group, resigned on Monday as Douglas Elliman’s executive chairman.
Lorber served as Elliman’s chairman for more than 20 years. He led the firm through its debut as a solo public company in 2021 after spinning off from its parent company, Vector Group ...
Two weeks before Howard Lorber retired as chairman and chief executive officer of Douglas Elliman Inc., he said at an internal inquiry that he had intimate relationships with two of the company’s ...
Michael Liebowitz, the newly appointed chairman and CEO of Douglas Elliman Inc., told agents ... the brokerage just before ...
Converting images into vector graphics or creating vector graphics is particularly useful if you need graphics for logos, illustrations, or print templates. While conventional image formats such ...
EXCLUSIVE: Montana's U.S. Senate race has one of the most "intense" ground games of the 2024 cycle with the chamber majority hanging in the balance, according to the chairman of the Republican ...
Add articles to your saved list and come back to them any time. It used to be that being a member of the Qantas Chairman’s Lounge or Virgin’s equivalent Beyond Lounge was the height of fashion ...
Kochi's district health department launches 'Aedes Hunt' campaign in Thrikkakara municipality to eradicate Aedes mosquito ...
Welcome to the Trade Desk third-quarter 2024 earnings conference call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host. Chris ...
Atos ATO0.63%increase; green up pointing triangle tapped Philippe Salle as its next chief executive officer and board chairman, putting an outsider with management experience across several ...
KARACHI: Amid an alarming rise in chikungunya cases in the metropolis, the Sindh Assembly was on Wednesday informed that ...
Steve Favaloro, Chairman and CEO, said, "I am thrilled to welcome Pam and Stuart to our board at an exciting time in Genezen's development. They bring a wealth of manufacturing, drug development, and ...